专利快速检索-快速检索全球专利，免费商用专利数据库-IPRDB

1. 发明公开

EP3716520A1 DISCONTINUOUS RECEPTION 有权转让
公开(公告)号：EP3716520A1
公开(公告)日：2020-09-30
申请号：EP20165724.4
申请日：2020-03-25
申请人： Babaei, Alireza , Dinan, Esmael , Yi, Yunjung , Zhou, Hua , Cirik, Ali , Rastegardoost, Nazanin , Jeon, Hyoungsuk , Kwak, Youngwoo , Xu, Kai , Hui, Bing
发明人： Babaei, Alireza , Dinan, Esmael , Yi, Yunjung , Zhou, Hua , Cirik, Ali , Rastegardoost, Nazanin , Jeon, Hyoungsuk , Kwak, Youngwoo , Xu, Kai , Hui, Bing
IPC分类号： H04L5/00 , H04L1/00 , H04W52/00
摘要： A wireless device receives a first downlink control information (DCI) scheduling a physical downlink shared channel (PDSCH). The first DCI comprises a feedback timing indicator field. In response to the feedback timing indicator field indicating not to transmit a feedback for the PDSCH before receiving a second DCI, a discontinuous reception (DRX) timer is started with a first value. A downlink control channel is monitored for the second DCI while the DRX timer is running.

2. 发明公开

EP1047439A1 PHARMACEUTICAL COMPOSITIONS AND METHOD OF USING SAME 有权
标题翻译：药物组合物含黄芩，在分离和纯化形式和制造方法的绿原酸和连翘
公开(公告)号：EP1047439A1
公开(公告)日：2000-11-02
申请号：EP99901358.4
申请日：1999-01-07
申请人： XU, Kai Jian
发明人： XU, Kai Jian
IPC分类号： A61K35/78 , C07H15/26 , C07H3/04
CPC分类号： C07H15/26 , A61K36/355 , A61K36/539 , A61K36/63 , C07H3/04 , Y02A50/473 , Y02A50/475 , Y02A50/481 , Y02A50/483 , A61K2300/00
摘要： The present invention provides a pharmaceutical composition comprising an extract or combination of extracts having an antiviral, antibacterial, or immunomodulating property, wherein the extract or combination of extracts is obtained from a combination of plants wherein at least one plant is selected from each of the genuses Labiatae, Caprifoliaceae, and Oleaceae. A preferred extract is obtained from Radix scutellaria, Flos lonicera, and Fructus forsythiae. The present invention further provides a pharmaceutical composition comprising baicalin, chlorogenic acid and forsythiaside in isolated and purified form. The present invention further provides certain novel derivatives of baicalin, chlorogenic acid and forsythiaside. The present invention additionally provides processes for preparing the extracts as well as baicalin, chlorogenic acid, and forsythiaside in isolated and purified forms.

3. 发明专利

AU2107599A Pharmaceutical compositions and method of using same 未知
公开(公告)号：AU2107599A
公开(公告)日：1999-07-26
申请号：AU2107599
申请日：1999-01-07
申请人： XU KAI JIAN
发明人： XU KAI JIAN
IPC分类号： A61K36/355 , A61K36/539 , A61K36/63 , C07H3/04 , C07H15/26 , A61K35/78
摘要： The present invention provides a pharmaceutical composition comprising an extract or combination of extracts having an antiviral, antibacterial, or immunomodulating property, wherein the extract or combination of extracts is obtained from a combination of plants wherein at least one plant is selected from each of the genuses Labiatae, Caprifoliaceae, and Oleaceae. A preferred extract is obtained from Radix scutellaria, Flos lonicera, and Fructus forsythiae. The present invention further provides a pharmaceutical composition comprising baicalin, chlorogenic acid and forsythiaside in isolated and purified form. The present invention further provides certain novel derivatives of baicalin, chlorogenic acid and forsythiaside. The present invention additionally provides processes for preparing the extracts as well as baicalin, chlorogenic acid, and forsythiaside in isolated and purified forms.

4. 发明公开

EP3734892A2 BANDWIDTH PART OPERATIONS 审中-公开
公开(公告)号：EP3734892A2
公开(公告)日：2020-11-04
申请号：EP20172060.4
申请日：2020-04-29
申请人： Dinan, Esmael , Hui, Bing , Zhou, Hua , Xu, Kai , Park, Kyungmin , Chae, Hyukjin , Yi, Yunjung
发明人： Dinan, Esmael , Hui, Bing , Zhou, Hua , Xu, Kai , Park, Kyungmin , Chae, Hyukjin , Yi, Yunjung
IPC分类号： H04L5/00 , H04W76/14
摘要： A wireless device receives one or more RRC messages comprising configuration parameters of a cell. The configuration parameters indicate uplink BWPs of an uplink carrier of the cell. The uplink BWPs comprise a first uplink BWP and a second uplink BWP. The configuration parameters further indicate a sidelink BWP of the uplink carrier of the cell. A numerology of the second uplink BWP is different than a numerology of the sidelink BWP. The wireless device activates the first uplink BWP. The wireless device activates the sidelink BWP The wireless device switches from the first uplink BWP to the second uplink BWP as an active uplink BWP. The wireless device deactivates, based on the switch, the sidelink BWP

5. 发明公开

EP3716698A1 CROSS-CARRIER SCHEDULING ACTIVATION FOR A DORMANT CELL 审中-实审转让
公开(公告)号：EP3716698A1
公开(公告)日：2020-09-30
申请号：EP20166431.5
申请日：2020-03-27
申请人： Yi, Yunjung , Dinan, Esmael , Zhou, Hua , Park, Kyungmin , Jeon, Hyoungsuk , Babaei, Alireza , Xu, Kai
发明人： Yi, Yunjung , Dinan, Esmael , Zhou, Hua , Park, Kyungmin , Jeon, Hyoungsuk , Babaei, Alireza , Xu, Kai
IPC分类号： H04W52/02
摘要： A wireless device receives one or more radio resource control (RRC) messages comprising configuration parameters. The configuration parameters indicate a first secondary cell (SCell) group comprising one or more first cells and a second SCell group comprising a plurality of second cells. The wireless device activates, in a non-dormant state, the one or more first cells and the plurality of second cells. In response to receiving a downlink control information indicating transitioning the first SCell group to a dormant state, the wireless device transitions the one or more first cells to the dormant state and maintains the plurality of second cells in the non-dormant state.

6. 发明授权

EP1047439B1 PHARMACEUTICAL COMPOSITION COMPRISING BAICALIN, CHLOROGENIC ACID AND FORSYTHIASIDE IN ISOLATED AND PURIFIED FORM AND METHOD OF PREPARATION 有权
标题翻译：药物组合物含黄芩，在分离和纯化形式和制造方法的绿原酸和连翘
公开(公告)号：EP1047439B1
公开(公告)日：2006-10-11
申请号：EP99901358.4
申请日：1999-01-07
申请人： XU, Kai Jian
发明人： XU, Kai Jian
IPC分类号： C07H15/26 , C07H3/04 , A61K36/00
CPC分类号： C07H15/26 , A61K36/355 , A61K36/539 , A61K36/63 , C07H3/04 , Y02A50/473 , Y02A50/475 , Y02A50/481 , Y02A50/483 , A61K2300/00
摘要： The present invention provides a pharmaceutical composition comprising an extract or combination of extracts having an antiviral, antibacterial, or immunomodulating property, wherein the extract or combination of extracts is obtained from a combination of plants wherein at least one plant is selected from each of the genuses Labiatae, Caprifoliaceae, and Oleaceae. A preferred extract is obtained from Radix scutellaria, Flos lonicera, and Fructus forsythiae. The present invention further provides a pharmaceutical composition comprising baicalin, chlorogenic acid and forsythiaside in isolated and purified form. The present invention further provides certain novel derivatives of baicalin, chlorogenic acid and forsythiaside. The present invention additionally provides processes for preparing the extracts as well as baicalin, chlorogenic acid, and forsythiaside in isolated and purified forms.

7. 发明专利

AT342270T 未知
公开(公告)号：AT342270T
公开(公告)日：2006-11-15
申请号：AT99901358
申请日：1999-01-07
申请人： XU KAI JIAN
发明人： XU KAI JIAN
IPC分类号： A61K36/355 , A61K36/539 , A61K36/63 , C07H3/04 , C07H15/26 , A61K36/00
摘要： The present invention provides a pharmaceutical composition comprising an extract or combination of extracts having an antiviral, antibacterial, or immunomodulating property, wherein the extract or combination of extracts is obtained from a combination of plants wherein at least one plant is selected from each of the genuses Labiatae, Caprifoliaceae, and Oleaceae. A preferred extract is obtained from Radix scutellaria, Flos lonicera, and Fructus forsythiae. The present invention further provides a pharmaceutical composition comprising baicalin, chlorogenic acid and forsythiaside in isolated and purified form. The present invention further provides certain novel derivatives of baicalin, chlorogenic acid and forsythiaside. The present invention additionally provides processes for preparing the extracts as well as baicalin, chlorogenic acid, and forsythiaside in isolated and purified forms.

8. 发明专利

DE69933539D1 未知
公开(公告)号：DE69933539D1
公开(公告)日：2006-11-23
申请号：DE69933539
申请日：1999-01-07
申请人： XU KAI JIAN
发明人： XU KAI JIAN
IPC分类号： C07H15/26 , A61K36/00 , A61K36/355 , A61K36/539 , A61K36/63 , C07H3/04
摘要： The present invention provides a pharmaceutical composition comprising an extract or combination of extracts having an antiviral, antibacterial, or immunomodulating property, wherein the extract or combination of extracts is obtained from a combination of plants wherein at least one plant is selected from each of the genuses Labiatae, Caprifoliaceae, and Oleaceae. A preferred extract is obtained from Radix scutellaria, Flos lonicera, and Fructus forsythiae. The present invention further provides a pharmaceutical composition comprising baicalin, chlorogenic acid and forsythiaside in isolated and purified form. The present invention further provides certain novel derivatives of baicalin, chlorogenic acid and forsythiaside. The present invention additionally provides processes for preparing the extracts as well as baicalin, chlorogenic acid, and forsythiaside in isolated and purified forms.

9. 发明专利

AU765951B2 Pharmaceutical compositions and method of using same 未知
公开(公告)号：AU765951B2
公开(公告)日：2003-10-02
申请号：AU2107599
申请日：1999-01-07
申请人： XU KAI JIAN
发明人： XU KAI JIAN
IPC分类号： A61K36/355 , A61K36/539 , A61K36/63 , C07H3/04 , C07H15/26 , A61K35/78
摘要： The present invention provides a pharmaceutical composition comprising an extract or combination of extracts having an antiviral, antibacterial, or immunomodulating property, wherein the extract or combination of extracts is obtained from a combination of plants wherein at least one plant is selected from each of the genuses Labiatae, Caprifoliaceae, and Oleaceae. A preferred extract is obtained from Radix scutellaria, Flos lonicera, and Fructus forsythiae. The present invention further provides a pharmaceutical composition comprising baicalin, chlorogenic acid and forsythiaside in isolated and purified form. The present invention further provides certain novel derivatives of baicalin, chlorogenic acid and forsythiaside. The present invention additionally provides processes for preparing the extracts as well as baicalin, chlorogenic acid, and forsythiaside in isolated and purified forms.

10. 发明专利

DE69933539T2 未知
公开(公告)号：DE69933539T2
公开(公告)日：2007-07-05
申请号：DE69933539
申请日：1999-01-07
申请人： XU KAI JIAN
发明人： XU KAI JIAN
IPC分类号： C07H15/26 , A61K36/00 , A61K36/355 , A61K36/539 , A61K36/63 , C07H3/04
摘要： The present invention provides a pharmaceutical composition comprising an extract or combination of extracts having an antiviral, antibacterial, or immunomodulating property, wherein the extract or combination of extracts is obtained from a combination of plants wherein at least one plant is selected from each of the genuses Labiatae, Caprifoliaceae, and Oleaceae. A preferred extract is obtained from Radix scutellaria, Flos lonicera, and Fructus forsythiae. The present invention further provides a pharmaceutical composition comprising baicalin, chlorogenic acid and forsythiaside in isolated and purified form. The present invention further provides certain novel derivatives of baicalin, chlorogenic acid and forsythiaside. The present invention additionally provides processes for preparing the extracts as well as baicalin, chlorogenic acid, and forsythiaside in isolated and purified forms.

你已经成功收藏专利！

检索式保存成功!

IPRDB

热门服务

关于我们

友情链接

联系方式